Skip to main content
DANAHER CORP /DE/ logo

DANAHER CORP /DE/ — Investor Relations & Filings

Ticker · DHR ISIN · US2358511028 LEI · S4BKK9OTCEWQ3YHPFM11 US Manufacturing
Filings indexed 2,516 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country US United States of America
Listing US DHR

About DANAHER CORP /DE/

https://www.danaher.com/

Danaher Corporation is a global science and technology company focused on improving human health. It operates across three primary segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment provides technologies and services to accelerate the development and commercialization of therapies, including biologics and cell and gene therapies. The Life Sciences segment offers tools and technologies that support scientific research and laboratory activities in areas such as molecular oncology and fluid filtration. The Diagnostics segment develops instruments, software, and reagents designed to deliver precise and rapid medical diagnoses. A core component of its strategy is the Danaher Business System (DBS), a proprietary management system that drives continuous improvement and operational excellence across its portfolio of businesses.

Recent filings

Filing Released Lang Actions
SD - DANAHER CORP /DE/ (0000313616) (Filer)
Regulatory Filings
2026-05-12 English
8-K - DANAHER CORP /DE/ (0000313616) (Filer)
Regulatory Filings
2026-05-07 English
NYSE CERTIFICATION
Regulatory Filings
2026-04-30 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-30 English
8-A12B
Regulatory Filings
2026-04-29 English
8-K
Regulatory Filings
2026-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.